January/February 2021

02/22/2021

It is now 2021—a new year where we have an opportunity to move forward with a fresh perspective. As we continue to contend with the ongoing COVID-19 pandemic, we have been reminded that we are a resilient and...

It is...

02/22/2021

Journal of Clinical Pathways

Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic

02/22/2021

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...

Health...

02/22/2021

Journal of Clinical Pathways

Positive Disruption in the COVID-19 Era: AMCCBS Virtual

02/22/2021

Association of Community Cancer Centers

The past year challenged cancer care professionals in ways that were seemingly unimaginable. With the spread of SARS-CoV-2 across the United States, cancer programs and practices were forced to dramatically change...

The...

02/22/2021

Journal of Clinical Pathways

We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access

02/22/2021

Marlon Graf , PhD;

T. Joseph Mattingly II, PhD, PharmD, MBA;

Stacey Hickson , PhD;

Jason Shafrin , PhD;

Christoph Glaetzer , Dipl Kfm;

Rifat Tuly , MPH;

Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...

...

02/22/2021

Journal of Clinical Pathways

Research Report

Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer

02/22/2021

Ashley A. Durand , MS;

Peter A.S. Johnstone , MD;

Dana E. Rollison , PhD;

Sandra C. Stewart , CTR;

Dung-Tsa Chen , PhD;

Yaroslav Shtogun , PhD;

David C. Boulware , MS;

Julio M. Pow-Sang , MD;

Karen A. Sereday , MS;

Karen K. Fields , MD;

Tracy C. Simpson , RCIS, FSICP, RN;

Abstract: We analyzed adherence to multidisciplinary clinical pathways to understand the impact on the cost of care for patients with prostate cancer. Methods: A retrospective cohort design identified 560 patients...

...

02/22/2021

Journal of Clinical Pathways

Column

COA Viewpoint

Meeting the Challenges of Community Oncology at the Virtual #COA2021

02/22/2021

Fred Divers , MD;

While the rollercoaster ride of 2020 is now over, the repercussions from events over those months will persist into 2021, creating new challenges for community oncology. How will practices adapt to the influx of new...

While...

02/22/2021

Journal of Clinical Pathways

Department

Research in Review

02/22/2021

JCP Editors

Reviewing the latest research on value-based care, clinical pathways, and precision medicine Patient-Provider Discussions About Cancer Treatment Costs Decrease Out-of-Pocket Spending Patient-provider discussions...

...

02/22/2021

Journal of Clinical Pathways

Feature

Research Report

Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer

02/22/2021

Ashley A. Durand , MS;

Peter A.S. Johnstone , MD;

Dana E. Rollison , PhD;

Sandra C. Stewart , CTR;

Dung-Tsa Chen , PhD;

Yaroslav Shtogun , PhD;

David C. Boulware , MS;

Julio M. Pow-Sang , MD;

Karen A. Sereday , MS;

Karen K. Fields , MD;

Tracy C. Simpson , RCIS, FSICP, RN;

...

02/22/2021

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

January/February 2021

Column

Department

Feature

Current Issue

Special Reports

Subscribe

Volume 7

Specialties

Events

Year Round Education

HMP Global Products